BMI1 belongs to polycomb group, and is associated with EMT, invasion and migration of cancer stem cells and chemoresistance; its lower expression is related to longer survival and favorable outcome in CRC patients [160]. The gene discussed is BMI1; the disease is colorectal carcinoma.